Your browser doesn't support javascript.
loading
Steady-state serum pharmacokinetics and bioequivalence of 500 mg oral versus 200 mg intravenous ciprofloxacin.
Garraffo, R; Dellamonica, P; Bernard, E; Etesse, H; Lapalus, P.
Afiliación
  • Garraffo R; Department of Clinical Pharmacology, Faculty of Medicine, L'Archet Hospital, Nice, France.
Int J Clin Pharmacol Res ; 9(1): 29-35, 1989.
Article en En | MEDLINE | ID: mdl-2707923
ABSTRACT
The pharmacokinetics of ciprofloxacin were examined after five days of treatment with 500 mg orally and 200 mg intravenously twice a day, in six healthy volunteers in an open, randomized crossover study. The ciprofloxacin concentrations were determined in serum by high performance liquid chromatography. The mean serum peak concentrations were obtained in 1 to 1.5 h by the oral route and the values reached were similar after the oral and intravenous dose (2.56 +/- 0.62 micrograms/ml and 2.6 +/- 0.67 micrograms/ml respectively). The terminal elimination half-life was about 4.5 h for oral form and 5 h for intravenous form. The absolute bioavailability of the oral ciprofloxacin was about 83%.
Asunto(s)
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Ciprofloxacina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Año: 1989 Tipo del documento: Article
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Ciprofloxacina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Año: 1989 Tipo del documento: Article